Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Analgesics, Opioid | 8 | 2022 | 498 | 2.290 |
Why?
|
| Pain, Postoperative | 7 | 2022 | 214 | 1.640 |
Why?
|
| Herniorrhaphy | 7 | 2021 | 38 | 1.590 |
Why?
|
| Tonsillectomy | 4 | 2021 | 69 | 1.530 |
Why?
|
| Practice Patterns, Physicians' | 6 | 2022 | 504 | 1.350 |
Why?
|
| Inappropriate Prescribing | 2 | 2019 | 27 | 1.270 |
Why?
|
| Specialties, Surgical | 2 | 2019 | 19 | 1.210 |
Why?
|
| Burns | 3 | 2020 | 83 | 0.880 |
Why?
|
| Surgeons | 2 | 2019 | 68 | 0.760 |
Why?
|
| Appendectomy | 3 | 2022 | 47 | 0.750 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 298 | 0.610 |
Why?
|
| Child | 13 | 2022 | 6405 | 0.540 |
Why?
|
| Appendicitis | 2 | 2013 | 55 | 0.540 |
Why?
|
| Retrospective Studies | 13 | 2022 | 7277 | 0.490 |
Why?
|
| Hospitalization | 1 | 2020 | 978 | 0.470 |
Why?
|
| Pediatrics | 2 | 2017 | 341 | 0.470 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 711 | 0.470 |
Why?
|
| Drug Prescriptions | 3 | 2020 | 135 | 0.460 |
Why?
|
| Enterobius | 1 | 2013 | 2 | 0.460 |
Why?
|
| Enterobiasis | 1 | 2013 | 3 | 0.460 |
Why?
|
| Appendix | 1 | 2013 | 9 | 0.450 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2013 | 3 | 0.450 |
Why?
|
| Heart Injuries | 1 | 2013 | 25 | 0.440 |
Why?
|
| Multiple Trauma | 1 | 2013 | 50 | 0.440 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2013 | 131 | 0.430 |
Why?
|
| Quality Improvement | 1 | 2017 | 413 | 0.430 |
Why?
|
| Child, Preschool | 9 | 2021 | 3187 | 0.400 |
Why?
|
| Clinical Competence | 1 | 2017 | 657 | 0.390 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2013 | 250 | 0.390 |
Why?
|
| Hernia, Umbilical | 2 | 2021 | 10 | 0.370 |
Why?
|
| Infant | 9 | 2021 | 2891 | 0.360 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1615 | 0.330 |
Why?
|
| Cell Lineage | 2 | 2006 | 146 | 0.320 |
Why?
|
| Hernia, Inguinal | 2 | 2020 | 21 | 0.300 |
Why?
|
| Liver | 1 | 2013 | 1118 | 0.300 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2006 | 245 | 0.290 |
Why?
|
| Chimerism | 1 | 2006 | 4 | 0.280 |
Why?
|
| Humans | 22 | 2022 | 68618 | 0.260 |
Why?
|
| Laparoscopy | 2 | 2020 | 237 | 0.260 |
Why?
|
| Incidence | 2 | 2022 | 1603 | 0.260 |
Why?
|
| Adolescent | 8 | 2021 | 8912 | 0.240 |
Why?
|
| Male | 12 | 2022 | 37321 | 0.220 |
Why?
|
| Female | 13 | 2022 | 38074 | 0.210 |
Why?
|
| Transplantation Tolerance | 3 | 2014 | 13 | 0.200 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 45 | 0.170 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2019 | 33 | 0.160 |
Why?
|
| Major Histocompatibility Complex | 4 | 2006 | 34 | 0.160 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 1054 | 0.160 |
Why?
|
| Length of Stay | 2 | 2020 | 780 | 0.160 |
Why?
|
| Biomedical Technology | 1 | 2018 | 14 | 0.160 |
Why?
|
| Hospitals, Pediatric | 2 | 2017 | 114 | 0.160 |
Why?
|
| Swine, Miniature | 6 | 2014 | 45 | 0.150 |
Why?
|
| Home Care Services | 1 | 2018 | 84 | 0.150 |
Why?
|
| Transplantation Chimera | 3 | 2006 | 10 | 0.150 |
Why?
|
| Patient Readmission | 1 | 2020 | 267 | 0.150 |
Why?
|
| Swine | 6 | 2014 | 672 | 0.140 |
Why?
|
| Kidney Transplantation | 3 | 2014 | 839 | 0.140 |
Why?
|
| Surgical Wound Infection | 1 | 2018 | 168 | 0.140 |
Why?
|
| Machine Learning | 1 | 2018 | 170 | 0.140 |
Why?
|
| Infant, Newborn | 6 | 2021 | 2455 | 0.140 |
Why?
|
| Decision Support Techniques | 1 | 2018 | 191 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2020 | 374 | 0.140 |
Why?
|
| Mobile Applications | 1 | 2018 | 138 | 0.140 |
Why?
|
| Ambulatory Care | 1 | 2018 | 340 | 0.130 |
Why?
|
| Cyclosporine | 2 | 2014 | 121 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 281 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 2 | 2005 | 149 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2018 | 2007 | 0.120 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2014 | 77 | 0.110 |
Why?
|
| Graft vs Host Disease | 2 | 2006 | 163 | 0.110 |
Why?
|
| Tricuspid Valve | 1 | 2013 | 42 | 0.110 |
Why?
|
| Abdomen, Acute | 1 | 2013 | 14 | 0.110 |
Why?
|
| Critical Pathways | 1 | 2013 | 33 | 0.110 |
Why?
|
| Unnecessary Procedures | 1 | 2013 | 49 | 0.110 |
Why?
|
| United States | 2 | 2022 | 7367 | 0.110 |
Why?
|
| Graft Rejection | 2 | 2014 | 458 | 0.100 |
Why?
|
| Algorithms | 1 | 2018 | 1196 | 0.100 |
Why?
|
| Colony-Forming Units Assay | 3 | 2006 | 78 | 0.100 |
Why?
|
| Occlusive Dressings | 1 | 2011 | 7 | 0.100 |
Why?
|
| Acute Disease | 1 | 2013 | 658 | 0.100 |
Why?
|
| Transplantation, Homologous | 3 | 2006 | 242 | 0.100 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2011 | 19 | 0.100 |
Why?
|
| beta-Glucans | 1 | 2011 | 18 | 0.100 |
Why?
|
| Pylorus | 1 | 2011 | 6 | 0.100 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2011 | 54 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2014 | 307 | 0.090 |
Why?
|
| Thoracic Injuries | 1 | 2011 | 44 | 0.090 |
Why?
|
| Internship and Residency | 1 | 2017 | 596 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2013 | 287 | 0.090 |
Why?
|
| Animals | 9 | 2014 | 20881 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1140 | 0.090 |
Why?
|
| Telemedicine | 1 | 2018 | 700 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2011 | 175 | 0.090 |
Why?
|
| Thymus Gland | 2 | 2006 | 97 | 0.080 |
Why?
|
| Treatment Outcome | 4 | 2020 | 7029 | 0.080 |
Why?
|
| Graft Survival | 3 | 2006 | 465 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 636 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 772 | 0.080 |
Why?
|
| Haploidy | 1 | 2006 | 2 | 0.070 |
Why?
|
| Granulocyte Precursor Cells | 1 | 2006 | 6 | 0.070 |
Why?
|
| Lymphocyte Count | 1 | 2006 | 53 | 0.070 |
Why?
|
| Transplantation Conditioning | 1 | 2006 | 34 | 0.070 |
Why?
|
| Platelet Count | 1 | 2006 | 100 | 0.070 |
Why?
|
| Histocompatibility Antigens | 1 | 2005 | 12 | 0.060 |
Why?
|
| Organ Transplantation | 1 | 2006 | 110 | 0.060 |
Why?
|
| Recurrence | 2 | 2020 | 948 | 0.060 |
Why?
|
| Spleen | 1 | 2005 | 301 | 0.060 |
Why?
|
| Immune Tolerance | 1 | 2005 | 114 | 0.060 |
Why?
|
| Cell Transplantation | 1 | 2004 | 22 | 0.060 |
Why?
|
| Transplantation | 1 | 2004 | 23 | 0.060 |
Why?
|
| Endogenous Retroviruses | 1 | 2004 | 1 | 0.060 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2004 | 37 | 0.060 |
Why?
|
| Wound Healing | 2 | 2018 | 260 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 2324 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 3259 | 0.050 |
Why?
|
| Immunosuppressive Agents | 3 | 2014 | 514 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 3 | 2006 | 492 | 0.040 |
Why?
|
| Flow Cytometry | 3 | 2006 | 489 | 0.040 |
Why?
|
| Aftercare | 1 | 2021 | 114 | 0.040 |
Why?
|
| Ultrasonography | 2 | 2013 | 453 | 0.040 |
Why?
|
| Patient Discharge | 1 | 2021 | 294 | 0.040 |
Why?
|
| Infant, Premature | 1 | 2020 | 284 | 0.040 |
Why?
|
| Videoconferencing | 1 | 2018 | 43 | 0.040 |
Why?
|
| Text Messaging | 1 | 2018 | 47 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 238 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 392 | 0.040 |
Why?
|
| Pregnancy | 3 | 2011 | 2334 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2020 | 2358 | 0.030 |
Why?
|
| Logistic Models | 1 | 2018 | 1420 | 0.030 |
Why?
|
| Needles | 1 | 2014 | 34 | 0.030 |
Why?
|
| Operative Time | 1 | 2014 | 45 | 0.030 |
Why?
|
| South Carolina | 1 | 2021 | 2752 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2014 | 24 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 2013 | 46 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2013 | 39 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 67 | 0.030 |
Why?
|
| Risk Factors | 2 | 2018 | 5731 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2013 | 100 | 0.030 |
Why?
|
| Emergency Medicine | 1 | 2013 | 88 | 0.030 |
Why?
|
| Education, Medical, Continuing | 1 | 2013 | 136 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 951 | 0.020 |
Why?
|
| Polyhydramnios | 1 | 2011 | 2 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2011 | 30 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2013 | 311 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2005 | 597 | 0.020 |
Why?
|
| Splenectomy | 1 | 2005 | 40 | 0.020 |
Why?
|
| Histocompatibility Testing | 1 | 2005 | 38 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2005 | 9 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 3705 | 0.020 |
Why?
|
| Isoantibodies | 1 | 2005 | 35 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2005 | 34 | 0.020 |
Why?
|
| Hematologic Diseases | 1 | 2005 | 20 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2005 | 74 | 0.020 |
Why?
|
| Uterus | 1 | 2005 | 77 | 0.020 |
Why?
|
| Fetal Diseases | 1 | 2005 | 64 | 0.020 |
Why?
|
| Prenatal Diagnosis | 1 | 2005 | 73 | 0.020 |
Why?
|
| Creatinine | 1 | 2005 | 243 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 2005 | 219 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2005 | 258 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2005 | 205 | 0.010 |
Why?
|
| Proviruses | 1 | 2004 | 8 | 0.010 |
Why?
|
| Haplotypes | 1 | 2004 | 174 | 0.010 |
Why?
|
| Models, Animal | 1 | 2005 | 252 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 62 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 2004 | 122 | 0.010 |
Why?
|
| Gestational Age | 1 | 2005 | 389 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2004 | 93 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2004 | 144 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 104 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2004 | 329 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 945 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2673 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2004 | 2550 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 4655 | 0.010 |
Why?
|